Association between EZH2 expression, silencing of tumor suppressors and disease outcome in solid tumors
| العنوان: | Association between EZH2 expression, silencing of tumor suppressors and disease outcome in solid tumors |
|---|---|
| المؤلفون: | Audrey Michaud, Michel Wassef, Raphaël Margueron |
| المصدر: | Cell Cycle |
| بيانات النشر: | Informa UK Limited, 2016. |
| سنة النشر: | 2016 |
| مصطلحات موضوعية: | 0301 basic medicine, tumor suppressor, macromolecular substances, Models, Biological, law.invention, Mice, 03 medical and health sciences, 0302 clinical medicine, Downregulation and upregulation, law, Prostate, Neoplasms, Biomarkers, Tumor, medicine, Animals, Humans, Gene silencing, Enhancer of Zeste Homolog 2 Protein, Genes, Tumor Suppressor, Gene Silencing, EZH2, Molecular Biology, Cyclin-Dependent Kinase Inhibitor p16, breast, Cell Line, Transformed, Cell Proliferation, Extra Views, prostate, biology, Cell growth, Cell Biology, solid tumors, PRC2, Polycomb, Treatment Outcome, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Immunology, Cancer cell, biology.protein, Cancer research, Suppressor, prognosis, Developmental Biology |
| الوصف: | EZH2, the main catalytic component of the Polycomb Repressive Complex 2 (PRC2) is apparently upregulated in most solid tumors. Furthermore its expression generally associates with poor prognosis. It was proposed that this correlation reflects a causal event, EZH2 mediating the silencing of key tumor suppressor loci. In contrast, we recently showed that EZH2 is dispensable for solid tumor development and that its elevated expression reflects the abnormally high proliferation rate of cancer cells. Here, we investigate the functional association between EZH2 expression and silencing of key tumor suppressor loci and further illustrate the confounding effect of proliferation on EZH2′s association to outcome. |
| تدمد: | 1551-4005 1538-4101 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::312f437642b1299704816b9d7dce6007Test https://doi.org/10.1080/15384101.2016.1208872Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....312f437642b1299704816b9d7dce6007 |
| قاعدة البيانات: | OpenAIRE |
| ResultId |
1 |
|---|---|
| Header |
edsair OpenAIRE edsair.doi.dedup.....312f437642b1299704816b9d7dce6007 831 3 unknown 831.319946289063 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....312f437642b1299704816b9d7dce6007&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
|
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Association between EZH2 expression, silencing of tumor suppressors and disease outcome in solid tumors
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Audrey+Michaud%22">Audrey Michaud</searchLink><br /><searchLink fieldCode="AR" term="%22Michel+Wassef%22">Michel Wassef</searchLink><br /><searchLink fieldCode="AR" term="%22Raphaël+Margueron%22">Raphaël Margueron</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Cell Cycle ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Informa UK Limited, 2016. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2016 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%220301+basic+medicine%22">0301 basic medicine</searchLink><br /><searchLink fieldCode="DE" term="%22tumor+suppressor%22">tumor suppressor</searchLink><br /><searchLink fieldCode="DE" term="%22macromolecular+substances%22">macromolecular substances</searchLink><br /><searchLink fieldCode="DE" term="%22Models%2C+Biological%22">Models, Biological</searchLink><br /><searchLink fieldCode="DE" term="%22law%2Einvention%22">law.invention</searchLink><br /><searchLink fieldCode="DE" term="%22Mice%22">Mice</searchLink><br /><searchLink fieldCode="DE" term="%2203+medical+and+health+sciences%22">03 medical and health sciences</searchLink><br /><searchLink fieldCode="DE" term="%220302+clinical+medicine%22">0302 clinical medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Downregulation+and+upregulation%22">Downregulation and upregulation</searchLink><br /><searchLink fieldCode="DE" term="%22law%22">law</searchLink><br /><searchLink fieldCode="DE" term="%22Prostate%22">Prostate</searchLink><br /><searchLink fieldCode="DE" term="%22Neoplasms%22">Neoplasms</searchLink><br /><searchLink fieldCode="DE" term="%22Biomarkers%2C+Tumor%22">Biomarkers, Tumor</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%22">medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Animals%22">Animals</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Gene+silencing%22">Gene silencing</searchLink><br /><searchLink fieldCode="DE" term="%22Enhancer+of+Zeste+Homolog+2+Protein%22">Enhancer of Zeste Homolog 2 Protein</searchLink><br /><searchLink fieldCode="DE" term="%22Genes%2C+Tumor+Suppressor%22">Genes, Tumor Suppressor</searchLink><br /><searchLink fieldCode="DE" term="%22Gene+Silencing%22">Gene Silencing</searchLink><br /><searchLink fieldCode="DE" term="%22EZH2%22">EZH2</searchLink><br /><searchLink fieldCode="DE" term="%22Molecular+Biology%22">Molecular Biology</searchLink><br /><searchLink fieldCode="DE" term="%22Cyclin-Dependent+Kinase+Inhibitor+p16%22">Cyclin-Dependent Kinase Inhibitor p16</searchLink><br /><searchLink fieldCode="DE" term="%22breast%22">breast</searchLink><br /><searchLink fieldCode="DE" term="%22Cell+Line%2C+Transformed%22">Cell Line, Transformed</searchLink><br /><searchLink fieldCode="DE" term="%22Cell+Proliferation%22">Cell Proliferation</searchLink><br /><searchLink fieldCode="DE" term="%22Extra+Views%22">Extra Views</searchLink><br /><searchLink fieldCode="DE" term="%22prostate%22">prostate</searchLink><br /><searchLink fieldCode="DE" term="%22biology%22">biology</searchLink><br /><searchLink fieldCode="DE" term="%22Cell+growth%22">Cell growth</searchLink><br /><searchLink fieldCode="DE" term="%22Cell+Biology%22">Cell Biology</searchLink><br /><searchLink fieldCode="DE" term="%22solid+tumors%22">solid tumors</searchLink><br /><searchLink fieldCode="DE" term="%22PRC2%22">PRC2</searchLink><br /><searchLink fieldCode="DE" term="%22Polycomb%22">Polycomb</searchLink><br /><searchLink fieldCode="DE" term="%22Treatment+Outcome%22">Treatment Outcome</searchLink><br /><searchLink fieldCode="DE" term="%22030104+developmental+biology%22">030104 developmental biology</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Eanatomical%5Fstructure%22">medicine.anatomical_structure</searchLink><br /><searchLink fieldCode="DE" term="%22030220+oncology+%26+carcinogenesis%22">030220 oncology & carcinogenesis</searchLink><br /><searchLink fieldCode="DE" term="%22Immunology%22">Immunology</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+cell%22">Cancer cell</searchLink><br /><searchLink fieldCode="DE" term="%22biology%2Eprotein%22">biology.protein</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+research%22">Cancer research</searchLink><br /><searchLink fieldCode="DE" term="%22Suppressor%22">Suppressor</searchLink><br /><searchLink fieldCode="DE" term="%22prognosis%22">prognosis</searchLink><br /><searchLink fieldCode="DE" term="%22Developmental+Biology%22">Developmental Biology</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => EZH2, the main catalytic component of the Polycomb Repressive Complex 2 (PRC2) is apparently upregulated in most solid tumors. Furthermore its expression generally associates with poor prognosis. It was proposed that this correlation reflects a causal event, EZH2 mediating the silencing of key tumor suppressor loci. In contrast, we recently showed that EZH2 is dispensable for solid tumor development and that its elevated expression reflects the abnormally high proliferation rate of cancer cells. Here, we investigate the functional association between EZH2 expression and silencing of key tumor suppressor loci and further illustrate the confounding effect of proliferation on EZH2′s association to outcome. ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1551-4005<br />1538-4101 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::312f437642b1299704816b9d7dce6007" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::312f437642b1299704816b9d7dce6007</link><br /><link linkTarget="URL" linkTerm="https://doi.org/10.1080/15384101.2016.1208872" linkWindow="_blank">https://doi.org/10.1080/15384101.2016.1208872</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => OPEN ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....312f437642b1299704816b9d7dce6007 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Languages] => Array
(
[0] => Array
(
[Text] => Undetermined
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 7
[StartPage] => 2256
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => 0301 basic medicine
[Type] => general
)
[1] => Array
(
[SubjectFull] => tumor suppressor
[Type] => general
)
[2] => Array
(
[SubjectFull] => macromolecular substances
[Type] => general
)
[3] => Array
(
[SubjectFull] => Models, Biological
[Type] => general
)
[4] => Array
(
[SubjectFull] => law.invention
[Type] => general
)
[5] => Array
(
[SubjectFull] => Mice
[Type] => general
)
[6] => Array
(
[SubjectFull] => 03 medical and health sciences
[Type] => general
)
[7] => Array
(
[SubjectFull] => 0302 clinical medicine
[Type] => general
)
[8] => Array
(
[SubjectFull] => Downregulation and upregulation
[Type] => general
)
[9] => Array
(
[SubjectFull] => law
[Type] => general
)
[10] => Array
(
[SubjectFull] => Prostate
[Type] => general
)
[11] => Array
(
[SubjectFull] => Neoplasms
[Type] => general
)
[12] => Array
(
[SubjectFull] => Biomarkers, Tumor
[Type] => general
)
[13] => Array
(
[SubjectFull] => medicine
[Type] => general
)
[14] => Array
(
[SubjectFull] => Animals
[Type] => general
)
[15] => Array
(
[SubjectFull] => Humans
[Type] => general
)
[16] => Array
(
[SubjectFull] => Gene silencing
[Type] => general
)
[17] => Array
(
[SubjectFull] => Enhancer of Zeste Homolog 2 Protein
[Type] => general
)
[18] => Array
(
[SubjectFull] => Genes, Tumor Suppressor
[Type] => general
)
[19] => Array
(
[SubjectFull] => Gene Silencing
[Type] => general
)
[20] => Array
(
[SubjectFull] => EZH2
[Type] => general
)
[21] => Array
(
[SubjectFull] => Molecular Biology
[Type] => general
)
[22] => Array
(
[SubjectFull] => Cyclin-Dependent Kinase Inhibitor p16
[Type] => general
)
[23] => Array
(
[SubjectFull] => breast
[Type] => general
)
[24] => Array
(
[SubjectFull] => Cell Line, Transformed
[Type] => general
)
[25] => Array
(
[SubjectFull] => Cell Proliferation
[Type] => general
)
[26] => Array
(
[SubjectFull] => Extra Views
[Type] => general
)
[27] => Array
(
[SubjectFull] => prostate
[Type] => general
)
[28] => Array
(
[SubjectFull] => biology
[Type] => general
)
[29] => Array
(
[SubjectFull] => Cell growth
[Type] => general
)
[30] => Array
(
[SubjectFull] => Cell Biology
[Type] => general
)
[31] => Array
(
[SubjectFull] => solid tumors
[Type] => general
)
[32] => Array
(
[SubjectFull] => PRC2
[Type] => general
)
[33] => Array
(
[SubjectFull] => Polycomb
[Type] => general
)
[34] => Array
(
[SubjectFull] => Treatment Outcome
[Type] => general
)
[35] => Array
(
[SubjectFull] => 030104 developmental biology
[Type] => general
)
[36] => Array
(
[SubjectFull] => medicine.anatomical_structure
[Type] => general
)
[37] => Array
(
[SubjectFull] => 030220 oncology & carcinogenesis
[Type] => general
)
[38] => Array
(
[SubjectFull] => Immunology
[Type] => general
)
[39] => Array
(
[SubjectFull] => Cancer cell
[Type] => general
)
[40] => Array
(
[SubjectFull] => biology.protein
[Type] => general
)
[41] => Array
(
[SubjectFull] => Cancer research
[Type] => general
)
[42] => Array
(
[SubjectFull] => Suppressor
[Type] => general
)
[43] => Array
(
[SubjectFull] => prognosis
[Type] => general
)
[44] => Array
(
[SubjectFull] => Developmental Biology
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Association between EZH2 expression, silencing of tumor suppressors and disease outcome in solid tumors
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Audrey Michaud
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Michel Wassef
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Raphaël Margueron
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 11
[M] => 08
[Type] => published
[Y] => 2016
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 15514005
)
[1] => Array
(
[Type] => issn-print
[Value] => 15384101
)
[2] => Array
(
[Type] => issn-locals
[Value] => edsair
)
[3] => Array
(
[Type] => issn-locals
[Value] => edsairFT
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 15
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Cell Cycle
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |